Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Aug 21, 2020 8:53am
201 Views
Post# 31437468

RE:Covid treatments - where are we @?

RE:Covid treatments - where are we @?aaaaacccchhhhh,,,it will soon be another year of lost time ,,of which we will never get back, slow retarding the development of RVX208,,,,,,it is clear that this drug may never get to maket while under the control of the present RVX management team. In order to advance,,we need an experienced CEO at the very least to clear a path forward or the technology to date be sold to BP who can actually keep the ongoing reserch in motion. As time passes our ability to defend the technology weakens. Every glitch in our development to date has extended the timeline out in years,,,,and it is very possibly never to be realize by present day shareholders. Cave men looking at a coke can !!!! ,,,,,the "we are very excited here at RVX" seems to have landed on deaf ears at best all these years???,,,,,of course it must be assumed jim jones's koolaid made people excited at the time as well.......
..Pitiful market cap with pitiful timelines,,,,,,,the market wont invest in such unknowns,,that is a basic principle when experienced investors assess where capital is going to be placed...it is very clear DMcC aint fooling the deep pockets out there,,,
<< Previous
Bullboard Posts
Next >>